Pilot evaluation of an optimized context-specific drug-drug interaction alerting system: A controlled pre-post study

International Journal of Medical Informatics

Volumn 84, Issue 9, 2014, Pages 617-629

  Cornu, Pieter ^a   Steurbaut, Stephane ^a   Gentens, Kristof ^b   Van de Velde, Rudi ^b   Dupont, Alain G ^a  

^a FACULTY OF MEDICINE AND PHARMACY   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Alert specificity; Clinical decision support systems; Drug drug interactions; Hospital; Pre post evaluation

Indexed keywords

ARTIFICIAL INTELLIGENCE; DECISION SUPPORT SYSTEMS; HOSPITALS; RISK ASSESSMENT;

ALERT SPECIFICITY; CLINICAL DECISION SUPPORT; CLINICAL DECISION SUPPORT SYSTEMS; DRUG-DRUG INTERACTIONS; INTERVENTION PERIOD; OPTIMIZATION STRATEGY; POST EVALUATIONS; POST INTERVENTIONS;

DRUG INTERACTIONS;

ADULT; ARTICLE; CLASSIFICATION ALGORITHM; COMPUTER PROGRAM; DECISION SUPPORT SYSTEM; EVALUATION STUDY; FEMALE; HUMAN; MALE; PHARMACIST; PILOT STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; UNIVERSITY HOSPITAL; ADOLESCENT; AGED; CHILD; COMPUTER ASSISTED DRUG THERAPY; DRUG INTERACTION; HOSPITAL INFORMATION SYSTEM; MEDICATION ERROR; MIDDLE AGED; PHYSICIAN; PRACTICE GUIDELINE; PREVENTION AND CONTROL; RISK FACTOR; UTILIZATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DECISION SUPPORT SYSTEMS, CLINICAL; DRUG INTERACTIONS; DRUG THERAPY, COMPUTER-ASSISTED; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MEDICAL ORDER ENTRY SYSTEMS; MEDICATION ERRORS; MIDDLE AGED; PHYSICIANS; PILOT PROJECTS; RISK FACTORS; YOUNG ADULT;

EID: 84946492237     PISSN: 13865056     EISSN: 18728243     Source Type: Journal    
DOI: 10.1016/j.ijmedinf.2015.05.005     Document Type: Article

References (52)

1. Classen D.C., Phansalkar S., Bates D.W. Critical drug-drug interactions for use in electronic health records systems with computerized physician order entry: review of leading approaches. J. Patient Saf. 2011, 7:61-65.
2. Espinosa-Bosch M., Santos-Ramos B., Gil-Navarro M.V., Santos-Rubio M.D., Marin-Gil R., Villacorta-Linaza P. Prevalence of drug interactions in hospital healthcare. Int. J. Clin. Pharm. 2012, 34:807-817.
3. Kuperman G.J., Bobb A., Payne T.H., Avery A.J., Gandhi T.K., Burns G., et al. Medication-related clinical decision support in computerized provider order entry systems: a review. J. Am. Med. Inform. Assoc. 2007, 14:29-40.
4. Osheroff J.A. Improving Medication Use and Outcomes with Clinical Decision Support: A Step-by-step Guide 2009, The Healthcare Information and Management Systems Society, Chicago, IL.
5. Horn J.R., Gumpper K.F., Hardy J.C., McDonnell P.J., Phansalkar S., Reilly C. Clinical decision support for drug-drug interactions: improvement needed. Am. J. Health Syst. Pharm. 2013, 70:905-909.
6. Phansalkar S., Desai A.A., Bell D., Yoshida E., Doole J., Czochanski M., et al. High-priority drug-drug interactions for use in electronic health records. J. Am. Med. Inform. Assoc. 2012, 19:735-743.
7. Shah N.R., Seger A.C., Seger D.L., Fiskio J.M., Kuperman G.J., Blumenfeld B., et al. Improving acceptance of computerized prescribing alerts in ambulatory care. J. Am. Med. Inform. Assoc. 2006, 13:5-11.
8. Payne T.H., Nichol W.P., Hoey P., Savarino J. Characteristics and override rates of order checks in a practitioner order entry system. Proc. AMIA Symp. 2002, 602-606.
9. van der Sijs H., Aarts J., Vulto A., Berg M. Overriding of drug safety alerts in computerized physician order entry. J. Am. Med. Inform. Assoc. 2006, 13:138-147.
10. Paterno M.D., Maviglia S.M., Gorman P.N., Seger D.L., Yoshida E., Seger A.C., et al. Tiering drug-drug interaction alerts by severity increases compliance rates. J. Am. Med. Inform. Assoc. 2009, 16:40-46.
11. Phansalkar S., van der Sijs H., Tucker A.D., Desai A.A., Bell D.S., Teich J.M., et al. Drug-drug interactions that should be non-interruptive in order to reduce alert fatigue in electronic health records. J. Am. Med. Inform. Assoc. 2013, 20:489-493.
12. Phansalkar S., Desai A., Yoshida E., Doole J., Czochanski M., Tucker A.D., et al. Criteria for assessing high-priority drug-drug interactions for clinical decision support in electronic health records. BMC Med. Inform. Decis. Mak. 2013, 13:65.
13. Slight S.P., Seger D.L., Nanji K.C., Cho I., Maniam N., Dykes P.C., et al. Are we heeding the warning signs?. Examining providers' overrides of computerized drug-drug interaction alerts in primary care. PLoS ONE 2013, 8:e85071.
14. Cornu P., Steurbaut S., Sostaric S., Mrhar A., Dupont A.G. Performance of a clinical decision support system and of clinical pharmacists in preventing drug-drug interactions on a geriatric ward. Int. J. Clin. Pharm. 2014, 36:519-525.
15. Seidling H.M., Klein U., Schaier M., Czock D., Theile D., Pruszydlo M.G., et al. What, if all alerts were specific-estimating the potential impact on drug interaction alert burden. Int. J. Med. Inform. 2014, 83:285-291.
16. Duke J.D., Morea J., Mamlin B., Martin D.K., Simonaitis L., Takesue B.Y., et al. Regenstrief Institute's Medical Gopher: a next-generation homegrown electronic medical record system. Int. J. Med. Inform. 2014, 83:170-179.
17. Duke J.D., Li X., Dexter P. Adherence to drug-drug interaction alerts in high-risk patients: a trial of context-enhanced alerting. J. Am. Med. Inform. Assoc. 2013, 20:494-498.
18. Cornu P., Steurbaut S., Beukeleer M.D., Putman K., Van de Velde R., Dupont A.G. Physician's expectations regarding prescribing clinical decision support systems in a Belgian hospital. Acta Clin. Belg. 2014, 69:157-164.
19. Harris A.D., McGregor J.C., Perencevich E.N., Furuno J.P., Zhu J., Peterson D.E., et al. The use and interpretation of quasi-experimental studies in medical informatics. J. Am. Med. Inform. Assoc. 2006, 13:16-23.
20. Friedman C.P., Wyatt J. Evaluation Methods in Biomedical Informatics 2006, Springer Science & Business Media, New York, NY. second ed.
21. Cornu P., Steurbaut S., Leysen T., De Baere E., Ligneel C., Mets T., et al. Effect of medication reconciliation at hospital admission on medication discrepancies during hospitalization and at discharge for geriatric patients. Ann. Pharmacother. 2012, 46:484-494.
22. Cornu P., Steurbaut S., Leysen T., De Baere E., Ligneel C., Mets T., et al. Discrepancies in medication information for the primary care physician and the geriatric patient at discharge. Ann. Pharmacother. 2012, 46:983-990.
23. Talmon J., Ammenwerth E., Brender J., de Keizer N., Nykanen P., Rigby M. STARE-HI--Statement on reporting of evaluation studies in Health Informatics. Int. J. Med. Inform. 2009, 78:1-9.
24. Brender J., Talmon J., de Keizer N., Nykanen P., Rigby M., Ammenwerth E. STARE-HI-statement on reporting of evaluation studies in health informatics: explanation and elaboration. Appl. Clin. Inform. 2013, 4:331-358.
25. Lanssiers R., Everaert E., De Win M., Van De Velde R., De Clercq H. An integrated drug prescription and distribution system: challenges and opportunities. Stud. Health Technol. Inform. 2002, 93:69-74.
26. Van de Velde R. Framework for a clinical information system. Int. J. Med. Inform. 2000, 57:57-72.
27. APB, DelphiCare APB, DelphiCare 2013, 〈http://delphicare.apb.be/DutchHTML/inbfLegende.html〉.
28. Horsky J., Phansalkar S., Desai A., Bell D., Middleton B. Design of decision support interventions for medication prescribing. Int. J. Med. Inform. 2013, 82:492-503.
29. van der Sijs H., van Gelder T., Vulto A., Berg M., Aarts J. Understanding handling of drug safety alerts: a simulation study. Int. J. Med. Inform. 2010, 79:361-369.
30. Duke J.D., Bolchini D. A successful model and visual design for creating context-aware drug-drug interaction alerts. AMIA Annu. Symp. Proc. 2011, 2011:339-348.
31. Resetar E., Reichley R.M., Noirot L.A., Dunagan W.C., Bailey T.C. Customizing a commercial rule base for detecting drug-drug interactions. AMIA Annu. Symp. Proc. 2005, 1094.
32. Phansalkar S., Edworthy J., Hellier E., Seger D.L., Schedlbauer A., Avery A.J., et al. A review of human factors principles for the design and implementation of medication safety alerts in clinical information systems. J. Am. Med. Inform. Assoc. 2010, 17:493-501.
33. Zachariah M., Phansalkar S., Seidling H.M., Neri P.M., Cresswell K.M., Duke J., et al. Development and preliminary evidence for the validity of an instrument assessing implementation of human-factors principles in medication-related decision-support systems-I-MeDeSA. J. Am. Med. Inform. Assoc. 2011, 1(18 Suppl.):i62-i72.
34. Feldstein A., Simon S.R., Schneider J., Krall M., Laferriere D., Smith D.H., et al. How to design computerized alerts to safe prescribing practices. Jt. Comm. J. Qual. Saf. 2004, 30:602-613.
35. Krall M.A., Sittig D.F. Clinician's assessments of outpatient electronic medical record alert and reminder usability and usefulness requirements. Proc. AMIA Symp. 2002, 400-404.
36. Carter J.H. Design and implementation issues. Clinical Decision Support Systems: Theory and Practice 2007, 64-98. Springer Science+Business Media, New York, NY. E.S. Berner (Ed.).
37. Lee J., Han H., Ock M., Lee S.I., Lee S., Jo M.W. Impact of a clinical decision support system for high-alert medications on the prevention of prescription errors. Int. J. Med. Inform. 2014, 83:929-940.
38. Ash J.S., Berg M., Coiera E. Some unintended consequences of information technology in health care: the nature of patient care information system-related errors. J. Am. Med. Inform. Assoc. 2004, 11:104-112.
39. Coiera E., Westbrook J., Wyatt J. The safety and quality of decision support systems. Yearb. Med. Inform. 2006, 20-25.
40. Weiner J.P., Kfuri T., Chan K., Fowles J.B. e-Iatrogenesis: the most critical unintended consequence of CPOE and other HIT. J. Am. Med. Inform. Assoc. 2007, 14:387-388. (discussion 89).
41. Sauer A.J., Newton-Cheh C. Clinical and genetic determinants of torsade de pointes risk. Circulation 2012, 125:1684-1694.
42. Yap Y.G., Camm A.J. Drug induced QT prolongation and torsades de pointes. Heart 2003, 89:1363-1372.
43. Bryant A.D., Fletcher G.S., Payne T.H. Drug interaction alert override rates in the meaningful use era: no evidence of progress. Appl. Clin. Inform. 2014, 5:802-813.
44. Smithburger P.L., Buckley M.S., Bejian S., Burenheide K., Kane-Gill S.L. A critical evaluation of clinical decision support for the detection of drug-drug interactions. Expert Opin. Drug Saf. 2011, 10:871-882.
45. van der Sijs H., Kowlesar R., Aarts J., Berg M., Vulto A., van Gelder T. Unintended consequences of reducing QT-alert overload in a computerized physician order entry system. Eur. J. Clin. Pharmacol. 2009, 65:919-925.
46. Sorita A., Bos J.M., Morlan B.W., Tarrell R.F., Ackerman M.J., Caraballo P.J. Impact of clinical decision support preventing the use of QT-prolonging medications for patients at risk for torsade de pointes. J. Am. Med. Inform. Assoc. 2014, epub ahead of print.
47. Strom B.L., Schinnar R., Aberra F., Bilker W., Hennessy S., Leonard C.E., et al. Unintended effects of a computerized physician order entry nearly hard-stop alert to prevent a drug interaction: a randomized controlled trial. Arch. Intern. Med. 2010, 170:1578-1583.
48. Bates D.W., Kuperman G.J., Wang S., Gandhi T., Kittler A., Volk L., et al. Ten commandments for effective clinical decision support: making the practice of evidence-based medicine a reality. J. Am. Med. Inform. Assoc. 2003, 10:523-530.
49. Campbell E.M., Sittig D.F., Ash J.S., Guappone K.P., Dykstra R.H. Types of unintended consequences related to computerized provider order entry. J. Am. Med. Inform. Assoc. 2006, 13:547-556.
50. van der Sijs H., Kowlesar R., Klootwijk A.P., Nelwan S.P., Vulto A.G., van Gelder T. Clinically relevant QTc prolongation due to overridden drug-drug interaction alerts: a retrospective cohort study. Br. J. Clin. Pharmacol. 2009, 67:347-354.
51. Bassi J., Lau F. Measuring value for money: a scoping review on economic evaluation of health information systems. J. Am. Med. Inform. Assoc. 2013, 20:792-801.
52. Moja L., Kwag K.H., Lytras T., Bertizzolo L., Brandt L., Pecoraro V., et al. Effectiveness of computerized decision support systems linked to electronic health records: a systematic review and meta-analysis. Am. J. Public Health 2014, 104:e1-e11.